Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study)

INTRODUCTION: Malignant cutaneous epithelial tumors comprise various skin malignancies originating from the cutaneous epithelium, including cutaneous squamous cell carcinoma, basal cell carcinoma, and malignant cutaneous adnexal tumors. Treatment options are limited, as the rarity of these tumors, e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishii, Maki, Hirai, Ikuko, Tanese, Keiji, Fusumae, Takayuki, Nakamura, Yoshio, Fukuda, Keitaro, Uchi, Hiroshi, Kabashima, Kenji, Otsuka, Atsushi, Yokota, Kenji, Yamazaki, Naoya, Namikawa, Kenjiro, Fujimura, Taku, Takenouchi, Tatsuya, Yamamoto, Yuki, Nishiguchi, Mana, Sato, Yasunori, Amagai, Masayuki, Funakoshi, Takeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4000
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598805/
https://www.ncbi.nlm.nih.gov/pubmed/33126349
http://dx.doi.org/10.1097/MD.0000000000022913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598805/
https://www.ncbi.nlm.nih.gov/pubmed/33126349
http://dx.doi.org/10.1097/MD.0000000000022913

Ejemplares similares